SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

IMF raises Israel’s 2026 growth forecast but sees weaker expansion in 2027

OpenWeb struggles to pay employees and suppliers as rescue hangs in the balance

Applied Materials opens a $5 billion center to help build the next generation of AI chips

Full list of Israeli high-tech funding rounds in 2026

Buzz

Most popular

Daily

Weekly

1

Lionel Messi is building a business empire that will outlast his football career

2

Microsoft Israel cuts hit AI agent team, with 50 Copilot Studio employees summoned to pre-dismissal hearings

3

CrowdStrike in advanced talks to acquire Israeli startup Orion for $500 million

4

Israel Shipyards signs €80 million deal to supply undisclosed vessel to foreign government

5

Amazon emerges as potential buyer of Israeli AI startup Decart at $7 billion

Undecimal Bio

1 stories about Undecimal Bio

יניב ארליך מנכ״ל Eleven Therapeutics שמפתח תרופות Nucleic acid

Undecimal Bio raises $18 million Seed to tackle a key obstacle in RNA medicines

The spinout from Eleven Therapeutics is developing an AI-enabled platform designed to deliver gene-silencing medicines to specific cells beyond the liver, where RNA-based treatments have had their greatest success.